Mind + Muscle

technical minds + legal muscle


dig deep

Biosimilar biologics: is the US being left behind?

  • 11.04.13
  • Paul Calvo
  • World Intellectual Property Review

Paul Calvo authored the article “Biosimilar Biologics: Is the US Being Left Behind?” published in the November/December issue of World Intellectual Property Review. The article discusses the status of biosimilar biologics for the United States and the U.S. Food and Drug Administration (FDA) compared to other agencies worldwide. Calvo states, "Europe continues to forge ahead with approval of increasingly complex biologics, while the US seems to be in a bit of a holding pattern as the final pieces of the regulatory puzzle for biosimilars fall into place."

To read the full article, visit the World Intellectual Property Review website

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.